Ajanta Pharma Ltd Analyst Rating
based on 11 analysts
63.64%
Buy
9.09%
Hold
27.27%
Sell
Based on 11 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹2992.82
Source: S&P Global Market Intelligence
Ajanta Pharma Ltd Share analysis
Ajanta Pharma Ltd price forecast by 11 analysts
Upside of4.47%
High
₹3665
Target
₹2992.82
Low
₹1981
Ajanta Pharma Ltd target price ₹2992.82, a slight upside of 4.47% compared to current price of ₹2864.8. According to 11 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Ajanta Pharma Ltd revenue growth forecast
Expected growth rate Q1, FY2026:26.22%
Forecast
Actual
Including amortisation and stock based compensations
Ajanta Pharma Ltd EPS growth forecast
EPS estimate Q1, FY2026:36.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Ajanta Pharma Ltd Performance
Day's Low
Day's High
₹2,842₹2,96252 Week's Low
52 Week's High
₹1,850.25₹3,485
| Returns % | |
| 1 Month Return | -4.05 % |
| 3 Month Return | -13.11 % |
| 1 Year Return | + 46.27 % |
| Market Stats | |
| Previous Close | ₹2,914.25 |
| Open | ₹2,929.60 |
| Volume | 1.37L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹36,402.51Cr |
Ajanta Pharma Ltd Key Statistics
| P/E Ratio | 41.17 |
| PEG Ratio | 2.35 |
| Market Cap | ₹36,402.51 Cr |
| P/B Ratio | 8.28 |
| EPS | 64.6 |
| Dividend Yield | 2.29 |
| Sector | Pharmaceuticals |
| ROE | 24.24 |
Ajanta Pharma Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹36,402.51 Cr | 66.86% | 0.51 | ₹816 Cr | ₹4,208 Cr | |
| BUY | ₹14,467.33 Cr | -2.21% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
| BUY | ₹72,870.26 Cr | 35.6% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
| HOLD | ₹98,409.68 Cr | 56.71% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
| BUY | ₹61,710.00 Cr | 25.5% | 0.53 | NA | NA |
Ajanta Pharma Ltd Mutual Fund Holdings
About Ajanta Pharma Ltd
Share Price: ₹2864.80 per share as on 06 Dec, 2024 04:01 PM
Market Capitalisation: ₹36,402.51Cr as of today
Revenue: ₹1,186.64Cr as on September 2024 (Q3 24)
Net Profit: ₹216.48Cr as on September 2024 (Q3 24)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
| Organisation | Ajanta Pharma Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Ajanta Pharma Ltd
Ajanta Pharma Shares Surge Ahead of Dividend - 05 Nov, 2024
Ajanta Pharma's share price increased by 3.70% as the company prepares for its ex-dividend date. An interim dividend of Rs 28 per share has been declared, with a record date set for November 6, 2024.Ajanta Pharma Declares Interim Dividend and Strong Q2 Results - 01 Nov, 2024
Ajanta Pharma Limited declared a 1400% interim dividend of Rs 28 per share, fixing November 6 as the record date. The company reported a 15% revenue increase to Rs 1,187 crore for Q2 FY25, with a profit after tax of Rs 216 crore, up 11% YOY. H1 FY25 performance also showed strong growth, with revenue up 14% and healthy cash flow metrics.Ajanta Pharma Reports Strong Q2 Growth and Dividend - 29 Oct, 2024
Ajanta Pharma's Q2 results show a 15% revenue increase to Rs 1,187 crore and a net profit rise of 11% to Rs 216 crore. The board declared a Rs 28 interim dividend. Overall, the company demonstrates solid financial performance.Ajanta Pharma Declares Record Dividend Amid Strong Earnings - 28 Oct, 2024
Ajanta Pharma reported strong Q2 results with a 15% revenue increase and 11% profit growth. The board declared a record ₹28 interim dividend, totaling ₹350 crore, marking a 1400% payout for shareholders.Ajanta Pharma Board to Consider Interim Dividend - 23 Oct, 2024
Ajanta Pharma Ltd. will hold a board meeting on October 28 to consider its first interim dividend for FY 2024-25. The record date for the dividend payment is set for November 6, 2024. Despite a 1.13% decline in share price to 2,943.65, the stock has appreciated over 35% in 2024.
Insights on Ajanta Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 14.84% to 14.93% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 8.36% to 9.11% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.08K Cr → 1.20K Cr (in ₹), with an average increase of 4.9% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 36.9%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 64.2% return, outperforming this stock by 17.9%
NEGATIVE IMPACTPrice Dip
In the last 7 days, AJANTPHARM stock has moved down by -5.3%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 245.77 Cr → 216.48 Cr (in ₹), with an average decrease of 11.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 7.94% to 7.52% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 66.27% to 66.26% in Sep 2024 quarter
Ajanta Pharma Ltd Financials
Index Inclusions
Ajanta Pharma Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 66.26% | ||
| Foreign Institutions | 9.11% | 8.96 | |
| Mutual Funds | 14.93% | 0.61 | |
| Retail Investors | 7.52% | ||
| Others | 2.18% |
Ajanta Pharma Ltd Key Indicators
Ajanta Pharma Ltd Valuation
Ajanta Pharma Ltd in the last 5 years
Lowest (17.12x)
June 6, 2018
Today (41.17x)
December 6, 2024
Industry (57.44x)
December 6, 2024
Highest (50.52x)
September 10, 2024
Ajanta Pharma Ltd Earnings and Dividends
Ajanta Pharma Ltd Earnings Results
Ajanta Pharma Ltd’s net profit jumped 10.84% since last year same period to ₹216.48Cr in the Q2 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated -11.92% fall in its net profits since last 3-months.
Read More about Earnings ResultsAjanta Pharma Ltd Dividends October,2024
In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28 - translating a dividend yield of 1.88%.
Read More about Dividends
Ajanta Pharma Ltd Technicals Summary
Bearish
Neutral
Bullish
Ajanta Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Ajanta Pharma Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Ajanta Pharma Ltd shares.
Ajanta Pharma Ltd (AJANTPHARM) share price today is ₹2864.8
Ajanta Pharma Ltd is listed on NSE
Ajanta Pharma Ltd is listed on BSE
- Today’s highest price of Ajanta Pharma Ltd is ₹2962.
- Today’s lowest price of Ajanta Pharma Ltd is ₹2842.
PE Ratio of Ajanta Pharma Ltd is 41.17
PE ratio = Ajanta Pharma Ltd Market price per share / Ajanta Pharma Ltd Earnings per share
Today’s traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 1.37L.
Today’s market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹36402.51Cr.
| Ajanta Pharma Ltd(AJANTPHARM | Price |
|---|---|
52 Week High | ₹3485 |
52 Week Low | ₹1850.25 |
Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2864.8. It is down -17.80% from its 52 Week High price of ₹3485
Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2864.8. It is up 54.83% from its 52 Week Low price of ₹1850.25
| Ajanta Pharma Ltd(AJANTPHARM | Returns |
|---|---|
1 Day Returns | -49.45% |
1 Month Returns | -4.05% |
3 Month Returns | -13.11% |
1 Year Returns | 46.27% |